Advanced Search
Disease Phase
Title Drug
Clinical Trials Listing
  • < Previous
  • 1
  • Next >
  • Penn Treatment Trials (5)
  • Penn Non-Treatment Trials (6)
  • Phase 1: Solid Tumor Trials (2)
  • Proton Therapy Trials (1)
Active treatment trials at Penn's Abramson Cancer Center
Protocol ID Title Phase Modality Drug
CALGB-30901 Randomized Phase II Study of Maintenance Pemetrexed Versus Observation for Patients With Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy II Chemotherapy pemetrexed
CLDE225A2112 A Phase Ib, Multi-center, Two Parallel Group, Open-label, Drug-drug Interaction Study to Assess the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients With Advanced Solid Tumors I Other warfarin; bupropion
CA186-011 A Phase 1 Study of the Safety, Tolerability, Pharmacokinetics and Immunoregulatory Activity of BMS-663513 (Anti-CD137) in Subjects With Advanced and/or Metastatic Solid Tumors I Immunotherapy BMS-663513
ADU-CL-02 A Phase 1B Study to Evaluate the Safety and Induction of Immune Response of CRS-207 in Combination With Pemetrexed and Cisplatin as Front-line Therapy in Adults With Malignant Pleural Mesothelioma I Chemotherapy, Immunotherapy pemetrexed; cisplatin; CRS-207
UPCC 02510 A Pilot And Feasibility Trial Evaluating Two Different Chemotherapy Regimens In Combination With Intrapleural Adenoviral-Mediated Interferon-Alpha Gene Transfer For Malignant Pleural Mesothelioma 0 Antineoplastic Agent, Chemotherapy recombinant adenovirus-interferon SCH 721015
Displaying: 1 - 5 of 5 Results
  • < Previous
  • 1
  • Next >